Updated News
Tuesday, 30-06-2026 | 08:40
Researchers led by Professor Akitsu Hotta from the Center for iPS Cell Research and Application (CIRA), Kyoto University, have developed a comprehensive framework to evaluate the safety of CRISPR-Cas9 genome editing therapies. The approach combines computer-based predictions, laboratory validation, and whole-genome analysis to identify both intended and unintended genetic changes.
